Skip to content

Acceptance and Efficacy of Live Supervision

Live Supervision Put to Test - Studies of Acceptance and Efficacy of Computer-assisted Live Supervision

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01510080
Enrollment
42
Registered
2012-01-13
Start date
2012-01-31
Completion date
2014-08-31
Last updated
2015-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Disorders

Keywords

Computer-assisted live supervision, Bug-in-the-eye supervision, Delayed video-based supervision, Cognitive behavioral therapy supervision

Brief summary

In order to meet an existing lack of empirical studies in the field of cognitive behavioral therapy supervision, the present randomized controlled trial is aimed at comparing two different types of supervision. This study compares computer-assisted live supervision and delayed video-based supervision regarding efficacy and acceptance among therapists, patients and supervisors. The efficacy of supervision is defined on different levels such as change of psychotherapeutic competence, nondisclosure, self-efficacy, self-awareness of the supervisee as well as therapeutic alliance, supervisory alliance and therapy outcome.

Interventions

BEHAVIORALComputer-assisted live supervision

8 BITE sessions, 4 video-based sessions (each 50 minutes) during treatment of 2 patients

BEHAVIORALDelayed video-based supervision

12 video-based sessions (each 50 minutes) during treatment of 2 patients

Sponsors

Central Institute of Mental Health, Mannheim
CollaboratorOTHER
Goethe University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Supervisees Inclusion Criteria: * Having successfully completed the interim audit * Having started to treat ambulant patients under supervision

Exclusion criteria

\- Patients Inclusion Criteria: * Meeting ICD 10 criteria for a mental disorder * Informed consent

Design outcomes

Primary

MeasureTime frameDescription
Supervisory Questionnaire (SQ)participants will be followed for the duration of psychotherapy, an expected average of 30 weeksself-report measure that assesses nondisclosure of the supervisee during supervision
Supervisee Levels Questionnaire (SLQ-R)participants will be followed for the duration of psychotherapy, an expected average of 30 weeksself-report measure that assesses self awareness, motivation and dependency- autonomy of supervisees
Counseling Self-Estimate Inventory (COSE)participants will be followed for the duration of psychotherapy, an expected average of 30 weeksself-report measure that assesses self efficacy of the supervisee
Fragebogen zur Psychotherapie-Supervision Kurzform (FSPT-K)participants will be followed for the duration of psychotherapy, an expected average of 30 weeksself-report measure that assesses level of development and supervision needs of the therapist

Secondary

MeasureTime frameDescription
Brief Symptom Inventory (BSI)participants will be followed for the duration of psychotherapy, an expected average of 30 weeksself-report measure that assesses aspects of general psychopathology
Health-related quality of life (SF-12)participants will be followed for the duration of psychotherapy, an expected average of 30 weeksself-report measure that assesses the health-related quality of life
Helping Alliance Questionnaire (HAQ)participants will be followed for the duration of psychotherapy, an expected average of 30 weeksself-report measure that assesses the therapeutic alliance
Stundenbogen zur Supervisionsbeurteilung (STEP SV)participants will be followed for the duration of psychotherapy, an expected average of 30 weeksself-report measure that assesses satisfaction with supervision
Cognitive Therapy Scale (CTS)participants will be followed for the duration of psychotherapy, an expected average of 30 weeksclinician-rated measure that assesses psychotherapeutic competencies
Client Satisfaction Questionnaire (CSQ8)participants will be followed for the duration of psychotherapy, an expected average of 30 weeksself-report measure that assesses satisfaction with therapy
Supervisory Working Alliance Inventory (SWAI)participants will be followed for the duration of psychotherapy, an expected average of 30 weeksself-report measure that assesses the supervisory relationship
Beck-Depression Inventory II (BDI-II)participants will be followed for the duration of psychotherapy, an expected average of 30 weeksself-report measure that assesses depressive symptoms
Beck Anxiety Inventory II (BAI)participants will be followed for the duration of psychotherapy, an expected average of 30 weeksself-report measure that asessses anxiety symptoms

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026